{
  "trial_id": "NCT02067741",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "Patient must give written informed consent before registration.",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Post-menopausal women",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Locally advanced or metastatic, histologically confirmed breast adenocarcinoma",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "requiring therapy and not suitable for local treatment.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Stratum A: endocrine responsive-HER2neg BC, specifically: ERpos (\u22651%), PRpos",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Presence of \u22651 measurable or evaluable lesion according to RECIST 1.1.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Tumor assessment to be performed within 28 days before or on registration.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "WHO performance status 0-1.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Age \u2265 18 years.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate hematological values: hemoglobin \u2265100 g/L, ANC \u22651.5x10^9/L, platelets \u2265100x10^9/L.",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate hepatic function: total bilirubin \u22641.5xULN, ALT \u22642.5xULN (except for liver metastases \u22645xULN).",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Adequate renal function: serum creatinine \u22641.5xULN.",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Previous malignancy within 5 years with the exception of adequately treated cervical carcinoma in situ or localized non-melanoma skin cancer.",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Uncontrolled central nervous system (CNS) metastases, pulmonary carcinomatous lymphangiosis (i.e., >50% invasion), or liver metastases on >1/3 of the liver on ultrasound or computed tomography (CT).",
      "label": "not_met",
      "evidence": "quote"
    },
    {
      "criterion": "Indication for chemotherapy.",
      "label": "not_met",
      "evidence": "unknown"
    }
  ],
  "notes": "45-year-old postmenopausal woman with cytologically confirmed breast cancer, HER2-positive and ER/PR negative. Axillary sampling revealed 5 positive lymph nodes.",
  "_meta": {
    "topic_id": "61",
    "trial_id": "NCT02067741",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}